Overview
Financials
Filing timeliness
The financial statement for 2025 was filed on time.
- 202506/07/2026
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- PET-CT scan
- Renal scintigraphy
- Bone scintigraphy
- Thyroid scintigraphy
- Radioisotope therapy
- Radiosynovectomy
Website technology
- Online shop
- WooCommerce
- Website
- WordPress
- Elementor
- Analytics and marketing
- Google Analytics
Public procurement
Nukleomed is the contractor in one public sector contract, worth USD 79.42k.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 21, 2026 | Wykonywanie wraz z opisem badań scyntygraficznych pacjentom leczonym w ramach szybkiej ścieżki onkologicznej | $79,417 | Radomski Szpital Specjalistyczny Im. Dr Tytusa Chałubińskiego |
National Health Fund (NFZ) contracts
Nukleomed has been an NFZ healthcare provider since 2025. In 2026 it is performing 3 contracts with a total value of USD 4.38m. All its contracts were worth USD 8.03m in total.
NFZ contract value by year (in k USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Separately contracted healthcare services | mazowieckie | 2 | USD 3.94m |
| Outpatient specialist care | mazowieckie | 1 | USD 439.48k |
NFZ waiting lists
This company's facilities run 4 NFZ waiting lists. Waiting time forecast by NFZ, as of 06.10.2026.
| Service | Waiting time | Urgent | Waiting | |
|---|---|---|---|---|
| Positron emission tomography | 27 days | 14 days | 19 | |
| Nuclear medicine clinic | 1 mo 3 wk | 1 mo 1 wk | 0 | |
| Isotope therapy | 2 mo | 1 mo 1 wk | 245 | |
| Nuclear medicine examinations | 4 mo 1 wk | 2 mo 3 wk | 557 |
Trademarks
Nukleomed holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2006.
| Mark | Protected until | |
|---|---|---|
| NUKLEOMED | May 17, 2036 |
Authorized Representatives
Manner of representation
Each member of the management board has the right to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Adam Edmund Tothage 39 | 800 | – | 0.08% |
Krzysztof Stefan Tothage 70 | 200 | – | 0.02% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2025-04-04.
52 1910 1048 2203 7749 4779 0002- 79 1910 1048 2203 7749 4779 0001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Prodomumsp. z o.o. | $40,062,555.38 | prodomum.pl | ||
| PB Bonasp. z o.o. | $391,074.84 | poradniabona.pl | ||
| DR Joanna Sanfordsp. k. | $28,674.82 | sanfordbiotech.com | ||
| Synaviesp. z o.o. | $440.48 | synavie.pl | ||
| O2zonesp. z o.o. | $0.00 | o2zone.pl | ||
| SIBO w Centrum Diagnostykasp. z o.o. | – | sibowcentrum.pl | ||
| LSMsp. z o.o. | – | lifestylemed.pl | ||
| Polski Bank Komórek Macierzystychsp. z o.o. | – | pbkm.pl | ||
| Artery MedtechS.A. | – | arterymed.com | ||
| Hoopifysp. z o.o. | – | hoopify.co |
FAQ
Last updated: 2026-07-09